Most of the eye outcomes were based on record review or provider report without adjudication by a study reading center
Diabetic peripheral neuropathy may result in a loss of protective sensation and cascade into the development of foot ulcers, wounds, infections, and tissue necrosis
Key takeaways Medicaid usually only covers GLP-1s if you are taking them for health conditions like Type 2 diabetes, cardiovascular risk reduction, or sleep apnea
Our approach is informed by the latest clinical studies, which show that patients often begin to notice changes in appetite and initial weight loss within the first few weeks of treatment
FAQ Your questions, answered Weve answered some of the most common questions below to help make your experience simple, transparent, and stress-free